These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9185505)

  • 21. Vasoactive intestinal peptide and pituitary adenylate cyclase activating polypeptide stimulate interleukin-6 production in prostate cancer cells and prostatic epithelial cells.
    Nagakawa O; Junicho A; Akashi T; Koizumi K; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2005 Jun; 13(6):1217-21. PubMed ID: 15870945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.
    Delgado M; Martinez C; Pozo D; Calvo JR; Leceta J; Ganea D; Gomariz RP
    J Immunol; 1999 Jan; 162(2):1200-5. PubMed ID: 9916753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semisynthetic sphingoglycolipid LIGA20 is neuroprotective against human immunodeficiency virus-gp120-mediated apoptosis.
    Bachis A; Mocchetti I
    J Neurosci Res; 2006 Apr; 83(5):890-6. PubMed ID: 16477610
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide enhance IL-10 production by murine macrophages: in vitro and in vivo studies.
    Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
    J Immunol; 1999 Feb; 162(3):1707-16. PubMed ID: 9973433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [AIDS and sleep disorders: effect of gp120 on cerebral glucose metabolism].
    Raymon LP; Kimes AS; Tabakoff B; London ED
    C R Seances Soc Biol Fil; 1989; 183(5):407-18. PubMed ID: 2561668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anorexigenic effects of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide in the chick brain are mediated by corticotrophin-releasing factor.
    Tachibana T; Saito ES; Takahashi H; Saito S; Tomonaga S; Boswell T; Furuse M
    Regul Pept; 2004 Aug; 120(1-3):99-105. PubMed ID: 15177926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates.
    Hill JM; Mervis RF; Avidor R; Moody TW; Brenneman DE
    Brain Res; 1993 Feb; 603(2):222-33. PubMed ID: 8461978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
    Delgado M; Jonakait GM; Ganea D
    Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of pituitary adenylate cyclase-activating polypeptide 38 (PACAP38) on tissue oxygen content--treatment in central nervous system of mice.
    Ohtaki H; Dohi K; Yofu S; Nakamachi T; Kudo Y; Endo S; Aruga T; Goto N; Watanabe J; Kikuyama S; Shioda S
    Regul Pept; 2004 Dec; 123(1-3):61-7. PubMed ID: 15518894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacologically distinct vasoactive intestinal peptide binding sites: CNS localization and role in embryonic growth.
    Hill JM; Lee SJ; Dibbern DA; Fridkin M; Gozes I; Brenneman DE
    Neuroscience; 1999; 93(2):783-91. PubMed ID: 10465461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of natural killer cell cytotoxicity and interferon gamma production by the envelope protein of HIV and prevention by vasoactive intestinal peptide.
    Peruzzi M; Azzari C; Rossi ME; De Martino M; Vierucci A
    AIDS Res Hum Retroviruses; 2000 Jul; 16(11):1067-73. PubMed ID: 10933622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vasoactive intestinal peptide shortens both G1 and S phases of neural cell cycle in whole postimplantation cultured mouse embryos.
    Gressens P; Paindaveine B; Hill JM; Evrard P; Brenneman DE
    Eur J Neurosci; 1998 May; 10(5):1734-42. PubMed ID: 9751145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death.
    Brenneman DE; Hauser J; Spong CY; Phillips TM; Pert CB; Ruff M
    Brain Res; 1999 Aug; 838(1-2):27-36. PubMed ID: 10446313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide: an important trophic factor and developmental regulator?
    Waschek JA
    Dev Neurosci; 1995; 17(1):1-7. PubMed ID: 7621745
    [TBL] [Abstract][Full Text] [Related]  

  • 36. gp120 as an etiologic agent for NeuroAIDS: neurotoxicity and model systems.
    Brenneman DE; McCune SK; Mervis RF; Hill JM
    Adv Neuroimmunol; 1994; 4(3):157-65. PubMed ID: 7874383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist.
    Glowa JR; Panlilio LV; Brenneman DE; Gozes I; Fridkin M; Hill JM
    Brain Res; 1992 Jan; 570(1-2):49-53. PubMed ID: 1617429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokines released from astroglia by vasoactive intestinal peptide. Mechanism of neuroprotection from HIV envelope protein toxicity.
    Brenneman DE; Hauser J; Spong CY; Phillips TM
    Ann N Y Acad Sci; 2000; 921():109-14. PubMed ID: 11193813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VIP neurotrophism in the central nervous system: multiple effectors and identification of a femtomolar-acting neuroprotective peptide.
    Brenneman DE; Glazner G; Hill JM; Hauser J; Davidson A; Gozes I
    Ann N Y Acad Sci; 1998 Dec; 865():207-12. PubMed ID: 9928014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide.
    Bassan M; Zamostiano R; Davidson A; Pinhasov A; Giladi E; Perl O; Bassan H; Blat C; Gibney G; Glazner G; Brenneman DE; Gozes I
    J Neurochem; 1999 Mar; 72(3):1283-93. PubMed ID: 10037502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.